Carisoprodol Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 250 mg, 350 mg
Reference Brands: Soma (USA/EU), Somadril (EU)
Category:
Analgesic
Carisoprodol is a centrally acting muscle relaxant used to relieve discomfort associated with acute musculoskeletal conditions such as muscle spasms, strains, and sprains. It works by blocking pain sensations between the nerves and the brain. Carisoprodol is usually prescribed for short-term use (up to 2–3 weeks) in combination with rest, physical therapy, and other treatments. It is available as oral tablets in strengths of 250 mg and 350 mg.
Carisoprodol is available in Tablets
and strengths such as 250 mg, 350 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Carisoprodol is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Carisoprodol can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Carisoprodol is a centrally acting skeletal muscle relaxant used for the short-term relief of acute musculoskeletal pain and discomfort associated with strains, sprains, and other muscle injuries. It is typically prescribed as part of a broader treatment plan that may include rest, physical therapy, and other supportive measures. After oral administration, the effect generally begins within about 30 minutes and may last up to six hours, helping reduce muscle spasm and improve mobility during the recovery period. Carisoprodol works by affecting communication between nerves in the central nervous system, leading to muscle relaxation and pain relief rather than acting directly on the muscles themselves. It is mainly intended for short-duration use due to the potential for dependence and sedation-related side effects. The product is commonly available in tablet form in multiple strengths and is marketed under several brand names globally, including Soma. Proper medical supervision is recommended to ensure safe and appropriate use.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing